Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: Impact of highly active antiretroviral therapy

AIDS Research and Human Retroviruses

Volumn 15, Issue 17, 1999, Pages 1499-1508

  Imami, Nesrina ^a,b   Antonopoulos, Chris ^a   Hardy, Gareth A D ^a   Gazzard, Brian ^a   Gotch, Frances M ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; LYMPHOCYTE COUNT; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON TYPE II; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; RNA, MESSENGER; RNA, VIRAL; VIRAL LOAD;

EID: 0033589663     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299309784     Document Type: Article

References (37)

1. Murray HW, Rubin BY, Masur H, and Roberts RB: Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med 1984;310: 883-889.
2. Epstein JS, Frederick WR, Rook AH, Jackson L, Manischewitz JF, Mayner RE, Masur H, Enterline JC, Djeu JY, and Quinnan GV Jr: Selective defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome. J Infect Dis 1985;152: 727-733.
3. Lane HC, Depper JM, Greene WC, Whalen G, Waldmann TA, and Fauci AS: Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med 1985; 313:79-84.
4. Lane HC and Fauci AS: Immunologic reconstitution in the acquired immunodeficiency syndrome. Ann Intern Med 1985; 103:714-718.
5. Giorgi JV, Fahey JL, Smith DC, Hultin LE, Cheng HL, Mitsuyasu RT, and Detels R: Early effects of HIV on CD4 lymphocytes in vivo. J Immunol 1987;138:3725-3730.
6. Koot M, van't Wout AB, Kootstra NA, de Goede RE, Tersmette M, and Schuitemaker H: Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection. J Infect Dis 1996;173:349-354.
7. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, and Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-1170.
8. Miedema F, Petit AJ, Terpstra FG, Schattenkerk JK, de Wolf F, Al BJ, Roos M, Lange JM, Danner SA, Goudsmit J, et al.: Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest 1988;82:1908-1914.
9. Laurence J, Friedman SM, Chartash EK, Crow MK, and Posnett DN: Human immunodeficiency virus infection of helper T cell clones. Early proliferative defects despite intact antigen-specific recognition and interleukin 4 secretion. J Clin Invest 1989; 83:1843-1848.
10. Clerici M, Stocks NI, Zajac RA, Boswell RN, Bernstein DC, Mann DL, Shearer GM, and Berzofsky JA: Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature (London) 1989;339:383-385.
11. Clerici M, Stocks NI, Zajac RA, Boswell RN, Lucey DR, Via CS, and Shearer GM: Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest 1989;84:1892-1899.
12. Maggi E, Macchia D, Parronchi P, Mazzetti M, Ravina A, Milo D, and Romagnani S: Reduced production of interleukin 2 and interferon gamma and enhanced helper activity for IgG synthesis by cloned CD4 T cells from patients with AIDS. Eur J Immunol 1987;17:1685-1690.
13. Clerici M, Hakim FT, Venzon DJ, Blatt SP, Hendrix CW, Wynn TA, and Shearer GM: Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993;91:759-765.
14. Clerici M, Wynn TA, Berzofsky JA, Blatt SP, Hendrix CW, Sher A, Coffman RL, and Shearer GM: Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with human immunodeficiency virus. J Clin Invest 1994;93:768-775.
15. Barcellini W, Rizzardi GP, Borghi MO, Fain C, Lazzarin A, and Meroni PL: Th1 and Th2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 1994;8: 757-762.
16. Errard F, Dunbar PR, and LeGros G: The IL-4 induced switch of CD8+ T cells to a Th2 phenotype and its possible relationship to the onset of AIDS. Res Immunol 1994;145:643-646.
17. Clerici M and Shearer GM: A Th1 → Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-111.
18. Clerici M and Shearer GM: The Th1-Th2 hypothesis of HIV infection: New insights. Immunol Today 1994;15:575-581.
19. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, and Walker BD: Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997;278:1447-1450.
20. Rosenberg ES and Walker BD: HIV type 1-specific helper T cells: A critical host defence. AIDS Res Hum Retroviruses 1998;14:S-143-147.
21. Matloubian M, Conception RJ, and Ahmed R: CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 1994;68:8056-8063.
22. Mackewicz CE, Blackbourn DJ, and Levy JA: CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci USA 1995;92:2308-2312.
23. Paxton WA, Martin SR, Tse D, O'Brien TR, Skurnick J, VanDevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM, and Koup RA: Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nature Med 1996;2:412-417.
24. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, and Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 1995;373:123-126.
25. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, et al.: Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 1995;373:117-122.
26. Pakker NG, Notermans DW, de Boer RJ, Ross MT, de Wolf F, Hill A, Leonard JM, Danner SA, Miedema F, and Schellekens PT: Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation. Nature Med 1995;4:208-214.
27. Wolthers KC, Schuitemaker H, and Miedema F: Rapid CD4+ T-cell turnover in HIV-1 infection: A paradigm revisited. Immunol Today 1998;19:44-48.
28. Kelleher AD, Carr A, Zaunders J, and Cooper DA: Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996;173:321-329.
29. Schnittman SM and Fox L: Preliminary evidence for partial restoration of immune function in HIV type 1 infection with potent antiretroviral therapies: Clues from the Fourth Conference on Retroviruses and Opportunistic Diseases. AIDS Res Hum Retroviruses 1997;13:815-818.
30. + T-cell repertoire that are not immediately restored by antiretroviral or immune-based therapies. Nature Med 1997;3: 533-540.
31. + T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-116.
32. Wolthers KC, Bea G, Wisman A, Otto SA, de Roda Husman AM, Schaft N, de Wolf F, Goudsmit J, Coutinho RA, van der Zee AG, Meyaard L, and Miedema F: T cell telomere length in HIV-1 infection: No evidence for increased CD4+ T cell turnover. Science 1996;274:1543-1547.
33. Swain SL: Generation and in vivo persistence of polarized Th1 and Th2 memory cells. Immunity 1994;1:543-552.
34. Dutton RW, Bradley LM, and Swain SL: T cell memory. Annu Rev Immunol 1998;16:201-223.
35. Sher A and Coffman RL: Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 1992;10:385-409.
36. Reiner SL and Locksley RM: The regulation of immunity to Leishmania major. Annu Rev Immunol 1995;13:151-177.
37. Boehm U, Klamp T, Groot M, and Howard JC: Cellular responses to interferon-γ. Annu Rev Immunol 1998;15:749-795.